Articles By Estel Grace Masangkay

  1. Roche Buys Biotech Firm Dutalys And Bina Technologies
    12/26/2014

    Roche announced that it has entered into agreement to acquire Vienna-based, private biotech firm Dutalys and its proprietary DutaMab technology for the discovery and development of fully human, bi-specific antibodies.

  2. Novartis Links With BiolineRX To Develop Israel-Made Drugs
    12/26/2014

    Israeli clinical-stage biopharmaceutical company BioLineRX announced that it has signed up Swiss pharma giant Novartis in a multi-year strategic collaboration to develop and commercialize Israeli-sourced drug candidates.

  3. Merck Acquires OncoEthix, Cancer Drug Lead
    12/23/2014

    Merck announced that it has acquired Swiss-based oncology firm OncoEthix through a subsidiary. The acquisition gives Merck access to an investigational drug in development for the treatment of blood malignancies and late-stage solid tumors.

  4. GSK’s Phase 3 Study For Shingles Vaccine Hits Endpoint
    12/23/2014

    GlaxoSmithKline announced positive results from its pivotal Phase 3 study investigating its vaccine HZ/su for the prevention of shingles.

  5. TxCell Wins EU Orphan Designation For Col-Treg In Uveitis
    12/22/2014

    Biotech firm TxCell announced that it has received orphan drug designation from the European Commission for its investigational immunotherapy Col-Treg intended for eye disease autoimmune uveitis.

  6. Alcon’s Xtoro For “Swimmer’s Ear” Gets FDA Green Light
    12/22/2014

    Novartis company, Alcon Laboratories, has received approval from the U.S. Food and Drug Administration (FDA) for its drug Xtoro (finafloxacin otic suspension) as treatment for acute otitis externa, also known as “swimmer’s ear.”

  7. CMC Biologics, OncoSynergy To Co-Develop Ebola Drug Lead
    12/18/2014

    CMC Biologics announced that it has entered into agreement with OncoSynergy for accelerated process development and Good Manufacturing Practices (GMP) production for the investigational drug OS2966 targeting the Ebola virus.

  8. AstraZeneca Posts Positive Data For Faslodex In Breast Cancer
    12/18/2014

    AstraZeneca presented new data for its investigational drug Faslodex (fulvestrant) as treatment for hormone-receptor positive breast cancer compared to Arimidex (anastrozole) at the recent 2014 San Antonio Breast Cancer Symposium (SABCS).

  9. Alkermes Begins Phase 1 Trial For Schizophrenia Drug
    12/18/2014

    Alkermes announced that it has started a Phase 1 study to investigate extended dosing intervals of aripiprazole lauroxil as treatment for schizophrenia.

  10. Pfizer To Develop GHD Drug With OPKO Health
    12/18/2014

    Pfizer announced it has partnered with Miami-based OPKO Health to develop the latter's long-acting hGH-CTP as treatment for growth hormone deficiency (GHD) syndrome in both adults and children, as well as for growth failure in children born small for gestational age (SGA) who fall short of catch-up growth standard by 2 years old.